BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6295260)

  • 1. Antipicornavirus flavone Ro 09-0179.
    Ishitsuka H; Ohsawa C; Ohiwa T; Umeda I; Suhara Y
    Antimicrob Agents Chemother; 1982 Oct; 22(4):611-6. PubMed ID: 6295260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410.
    Ishitsuka H; Ninomiya YT; Ohsawa C; Fujiu M; Suhara Y
    Antimicrob Agents Chemother; 1982 Oct; 22(4):617-21. PubMed ID: 6295261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.
    Otto MJ; Fox MP; Fancher MJ; Kuhrt MF; Diana GD; McKinlay MA
    Antimicrob Agents Chemother; 1985 Jun; 27(6):883-6. PubMed ID: 2992365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of 3-methylquercetin on poliovirus RNA replication.
    Castrillo JL; Carrasco L
    J Virol; 1987 Oct; 61(10):3319-21. PubMed ID: 2442414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoxazoles with antipicornavirus activity.
    Diana GD; McKinlay MA; Brisson CJ; Zalay ES; Miralles JV; Salvador UJ
    J Med Chem; 1985 Jun; 28(6):748-52. PubMed ID: 2989517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity and mechanism of action of 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile (MDL-860).
    Torney HL; Dulworth JK; Steward DL
    Antimicrob Agents Chemother; 1982 Oct; 22(4):635-8. PubMed ID: 7181474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipoliovirus activity of isothiazole derivatives: mode of action of 5,5'-diphenyl-3,3'-diisothiazole disulfide (DID).
    Garozzo A; Pinizzotto MR; Guerrera F; Tempera G; Castro A; Geremia E
    Arch Virol; 1994; 135(1-2):1-11. PubMed ID: 8198435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipoliovirus flavonoids from Psiadia dentata.
    Robin V; Irurzun A; Amoros M; Boustie J; Carrasco L
    Antivir Chem Chemother; 2001 Sep; 12(5):283-91. PubMed ID: 11900347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance.
    Geller R; Vignuzzi M; Andino R; Frydman J
    Genes Dev; 2007 Jan; 21(2):195-205. PubMed ID: 17234885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of picornavirus uncoating as antiviral agents.
    Diana GD; Otto MJ; McKinlay MA
    Pharmacol Ther; 1985; 29(3):287-97. PubMed ID: 3014575
    [No Abstract]   [Full Text] [Related]  

  • 11. SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.
    Rozhon E; Cox S; Buontempo P; O'Connell J; Slater W; De Martino J; Schwartz J; Miller G; Arnold E; Zhang A
    Antiviral Res; 1993 May; 21(1):15-35. PubMed ID: 8391247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipicornavirus activity of substituted phenoxybenzenes and phenoxypyridines.
    Markley LD; Tong YC; Dulworth JK; Steward DL; Goralski CT; Johnston H; Wood SG; Vinogradoff AP; Bargar TM
    J Med Chem; 1986 Mar; 29(3):427-33. PubMed ID: 3005578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.
    Woods MG; Diana GD; Rogge MC; Otto MJ; Dutko FJ; McKinlay MA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2069-74. PubMed ID: 2559655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral agents against picornaviruses.
    Eggers HJ
    Antiviral Res; 1985; Suppl 1():57-65. PubMed ID: 3002267
    [No Abstract]   [Full Text] [Related]  

  • 15. Chiral discrimination and antipicornavirus activity of 6-oxazolinylisoflavan.
    Quaglia MG; Desideri N; Bossù E; Sestili I; Tomao P; Conti C; Orsi N
    Chirality; 1993; 5(5):356-8. PubMed ID: 8398593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-human rhinovirus 2 activity and mode of action of quercetin-7-glucoside from Lagerstroemia speciosa.
    Song JH; Park KS; Kwon DH; Choi HJ
    J Med Food; 2013 Apr; 16(4):274-9. PubMed ID: 23566054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity.
    Rosenwirth B; Oren DA; Arnold E; Kis ZL; Eggers HJ
    Antiviral Res; 1995 Jan; 26(1):65-82. PubMed ID: 7741522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the impact of quercetin-7-O-glucoside on influenza virus replication influence.
    Gansukh E; Kazibwe Z; Pandurangan M; Judy G; Kim DH
    Phytomedicine; 2016 Aug; 23(9):958-67. PubMed ID: 27387404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipicornavirus activity of SCH 47802 and analogs: in vitro and in vivo studies.
    Cox S; Buontempo PJ; Wright-Minogue J; DeMartino JL; Skelton AM; Ferrari E; Schwartz J; Rozhon EJ; Linn CC; Girijavallabhan V; O'Connell JF
    Antiviral Res; 1996 Oct; 32(2):71-9. PubMed ID: 8891166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.
    Klumpp K; Kalayanov G; Ma H; Le Pogam S; Leveque V; Jiang WR; Inocencio N; De Witte A; Rajyaguru S; Tai E; Chanda S; Irwin MR; Sund C; Winqist A; Maltseva T; Eriksson S; Usova E; Smith M; Alker A; Najera I; Cammack N; Martin JA; Johansson NG; Smith DB
    J Biol Chem; 2008 Jan; 283(4):2167-75. PubMed ID: 18003608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.